BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raue R, Frank AC, Syed SN, Brüne B. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment. Int J Mol Sci 2021;22:2210. [PMID: 33672261 DOI: 10.3390/ijms22042210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Meng Q, Deng Y, lu Y, Wu C, Tang S. Tumor-derived miRNAs as tumor microenvironment regulators for synergistic therapeutic options. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04432-0] [Reference Citation Analysis]
2 Jafarzadeh A, Noori M, Sarrafzadeh S, Tamehri Zadeh SS, Nemati M, Chatrabnous N, Jafarzadeh S, Hamblin MR, Jafari Najaf Abadi MH, Mirzaei H. MicroRNA-383: A tumor suppressor miRNA in human cancer. Front Cell Dev Biol 2022;10:955486. [DOI: 10.3389/fcell.2022.955486] [Reference Citation Analysis]
3 Gaponova S, Patutina O, Sen'kova A, Burakova E, Savin I, Markov A, Shmendel E, Maslov M, Stetsenko D, Vlassov V, Zenkova M. Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy. Cancers (Basel) 2022;14:4396. [PMID: 36139555 DOI: 10.3390/cancers14184396] [Reference Citation Analysis]
4 Hashemi Doulabi MS, Ghaedi K, Ranji N, Khazaei Koohpar Z. rs5745676 of HGF 3’UTR associates with hsa-miR-340-5p binding potential in breast cancer and gastric cancer in Isfahan population. Human Gene 2022;33:201075. [DOI: 10.1016/j.humgen.2022.201075] [Reference Citation Analysis]
5 Megahed MA, El-Sawy HS, Reda AM, Abd-Allah FI, Abu Elyazid SK, Lila AE, Ismael HR, El-Say KM. Effect of nanovesicular surface-functionalization via chitosan and/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model. Life Sci 2022;307:120908. [PMID: 36028168 DOI: 10.1016/j.lfs.2022.120908] [Reference Citation Analysis]
6 Mafi A, Rahmati A, Babaei Aghdam Z, Salami R, Salami M, Vakili O, Aghadavod E. Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment. Cell Mol Biol Lett 2022;27:65. [PMID: 35922753 DOI: 10.1186/s11658-022-00354-4] [Reference Citation Analysis]
7 Jayasingam SD, Citartan M, Mat Zin AA, Rozhdestvensky TS, Tang T, Ch’ng ES. An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer. IJMS 2022;23:6994. [DOI: 10.3390/ijms23136994] [Reference Citation Analysis]
8 Syed SN, Brüne B. Exosomal and Non-Exosomal MicroRNAs: New Kids on the Block for Cancer Therapy. Int J Mol Sci 2022;23:4493. [PMID: 35562884 DOI: 10.3390/ijms23094493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lin F, Li R. MiR-1226, mediated by ASCL1, suppresses the progression of non-small cell lung cancer by targeting FGF2. Bulletin du Cancer 2022. [DOI: 10.1016/j.bulcan.2021.11.017] [Reference Citation Analysis]
10 Veiga RN, Zambalde ÉP, Cox L, Jucoski TS, Kohler AF, Carvalho TM, Rodrigues AC, Ludwig B, Crowley K, de Oliveira JC, Cortez MA. Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-031-08356-3_3] [Reference Citation Analysis]
11 Jafarzadeh A, Paknahad MH, Nemati M, Jafarzadeh S, Mahjoubin-Tehran M, Rajabi A, Shojaie L, Mirzaei H. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target. Biomed Pharmacother 2021;146:112600. [PMID: 34968919 DOI: 10.1016/j.biopha.2021.112600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Conte E. Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches. Pharmacol Ther 2021;:108031. [PMID: 34774879 DOI: 10.1016/j.pharmthera.2021.108031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Shiah SG, Chou ST, Chang JY. MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:5604. [PMID: 34830755 DOI: 10.3390/cancers13225604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hesse E, Jakob F, Taipaleenmäki H. Update on MicroRNA-based Treatment Strategies. Osteologie 2021;30:243-250. [DOI: 10.1055/a-1545-7927] [Reference Citation Analysis]
15 Matarrese P, Mattia G, Pagano MT, Pontecorvi G, Ortona E, Malorni W, Carè A. The Sex-Related Interplay between TME and Cancer: On the Critical Role of Estrogen, MicroRNAs and Autophagy. Cancers (Basel) 2021;13:3287. [PMID: 34209162 DOI: 10.3390/cancers13133287] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Odle AK, MacNicol MC, Childs GV, MacNicol AM. Post-Transcriptional Regulation of Gnrhr: A Checkpoint for Metabolic Control of Female Reproduction. Int J Mol Sci 2021;22:3312. [PMID: 33805020 DOI: 10.3390/ijms22073312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]